Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, will present a corporate update at the Jefferies 2019 Healthcare Conference on Tuesday, June 4, 2019 at 4:00 pm EST. The conference will be held June 4-7, 2019 in New York.
May 28, 2019
· 1 min read